Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms
Clinical trial NCT06185985 · COMPLETED
Trial details
- NCT number
- NCT06185985
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2024-12-03
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.